Search Within

Hebert Alberto Vargas Alvarez

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (9)
  2. Meeting Abstract (2)
Groups
  1. Human Oncology and Pathogenesis Program (11)
  2. Molecular Imaging and Therapy Service (11)
  3. Department of Medicine (10)
  4. Department of Pathology and Laboratory Medicine (10)
  5. Genitourinary Oncology Service (10)
  6. Solid Tumor Oncology Division (10)

More Groups

People
  1. David Solit (6)
  2. Abraham Hakimi (5)
  3. Gopakumar Iyer (5)
  4. Hikmat Al-Ahmadie (5)
  5. Howard Scher (5)
  6. Jonathan Rosenberg (5)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (2)
  4. 2022 (1)
  5. 2020 (1)
  6. 2019 (1)

More Years

Publications
  1. Journal of Clinical Oncology (4)
  2. JAMA Oncology (2)
  3. Cancer Imaging (1)
  4. Clinical Cancer Research (1)
  5. JCO Precision Oncology (1)
  6. Nature Communications (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (5)
  2. American Medical Association (2)
  3. American Association for Cancer Research (1)
  4. Biomed Central Ltd (1)
  5. Nature Publishing Group (1)
  6. Springer Nature (1)

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Updated long-term follow-up from a phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy for patients with high-grade upper tract urothelial carcinoma
    Meeting Abstract

    Jayalath, V.; Teo, M. Y.; Assel, M.; Rodriguez, D.; Meyerson, A.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Cha, E. K.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Microsatellite instability, tumor mutational burden, and response to immune checkpoint blockade in patients with prostate cancer
    Journal Article

    Lenis, A. T.; Ravichandran, V.; Brown, S.; Alam, S. M.; Katims, A.; Truong, H.; Reisz, P. A.; Vasselman, S.; Nweji, B.; Autio, K. A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapy
    Journal Article

    Walmsley, C. S.; Jonsson, P.; Cheng, M. L.; McBride, S.; Kaeser, C.; Vargas, H. A.; Laudone, V.; Taylor, B. S.; Kappagantula, R.; Baez, P.; more...
    npj Precision Oncology (2024)

    Fulltext@MSK | Save
  • Multicenter phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy for patients with high-grade upper tract urothelial carcinoma
    Journal Article

    Coleman, J. A.; Yip, W.; Wong, N. C.; Sjoberg, D. D.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Cha, E. K.; Donahue, T. F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Sarcomatoid renal cell carcinoma: MRI features and their association with survival
    Journal Article

    Cheng, M.; Duzgol, C.; Kim, T. H.; Ghafoor, S.; Becker, A. S.; Causa Andrieu, P. I.; Gangai, N.; Jiang, H.; Hakimi, A. A.; Vargas, H. A.; more...
    Cancer Imaging (2023)

    Fulltext@MSK | Save
  • Final results of a multicenter prospective phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy in patients with high-grade upper tract urothelial carcinoma
    Meeting Abstract

    Yip, W.; Coleman, J.; Wong, N. C.; Sjoberg, D. D.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Pietzak, E. J.; Hakimi, A. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts
    Journal Article

    Kim, K.; Hu, W.; Audenet, F.; Almassi, N.; Hanrahan, A. J.; Murray, K.; Bagrodia, A.; Wong, N.; Clinton, T. N.; Dason, S.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • Analysis of the prevalence of microsatellite instability in prostate cancer and response to immune checkpoint blockade
    Journal Article

    Abida, W.; Cheng, M. L.; Armenia, J.; Middha, S.; Autio, K. A.; Vargas, H. A.; Rathkopf, D.; Morris, M. J.; Danila, D. C.; Slovin, S. F.; more...
    JAMA Oncology (2019)

    Fulltext@MSK | Save
  • Multicenter prospective phase II trial of neoadjuvant dose-dense gemcitabine plus cisplatin in patients with muscle-invasive bladder cancer
    Journal Article

    Iyer, G.; Balar, A. V.; Milowsky, M. I.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Huang, W. C.; Taneja, S. S.; Woods, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Positron emission tomography/computed tomography-based assessments of androgen receptor expression and glycolytic activity as a prognostic biomarker for metastatic castration-resistant prostate cancer
    Journal Article

    Fox, J. J.; Gavane, S. C.; Blanc-Autran, E.; Nehmeh, S.; Gonen, M.; Beattie, B.; Vargas, H. A.; Schoder, H.; Humm, J. L.; Fine, S. W.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save